oratory blood tests showed an elevated C-reactive protein (CRP) level (23.52 mg/dL), erythrocyte sedimentation rate (ESR) (78 mm/hr) and RA factor (182.00 IU/mL). Anti-cyclic citrullinated peptide antibody (anti-CCP), anti-beta 2 GP1 IgG and anti-beta 2 GP1 IgM were positive. Both serum and CSF tests for Anti-Hu, Anti-Yo, Anti-Ri, CV2/CRMP5, NM-DAR, AMPA1, AMPA2, LG1, GABA-B, and Caspr2 antibodies were negative. Neoplastic serum markers (carcinoembryonic antigen, alpha-feto protein, CA125, CA19-9) were negative. A chest and abdominal CT scan showed no signs of malignancy.
We made a diagnosis of non-paraneoplastic LE without detectable antineuronal antibodies. Also, clinical feature of swollen PIP and knee joints with abnormal acute-reactants (CRP and ESR) and positive serology (RF and anti-CCP) was consistent with RA. She was treated with a course of high dose steroids. Her memory impairment was improved after 10 days. Two weeks later, a follow-up brain MRI demonstrated the disappearance of high signal intensities in bilateral medial temporal lobes (Fig. 1C) . For RA, she was prescribed 7.5 mg/ week of methotrexate, 1 mg/day of folic acid and 400 mg/day of hydroxychloroquine.
Herein, we described a patient with non-paraneoplastic LE accompanied by RA. Reports of LE combined with various connective tissue diseases are rare. We only found some reports on LE combined with Sjogren's syndrome, and LE following immunotherapy for RA. [2] [3] [4] It is possible that the immunologic mechanism of RA contributed to the pathogenesis of LE in our patient. However, associated biological mechanism 
